质子泵抑制剂与肾脏:当前证据对临床实践的启示及何时如何减处方
本文为In Practice综述,总结质子泵抑制剂(PPI)使用与低镁血症、急性肾损伤、急性间质性肾炎、慢性肾脏病、肾病进展、肾衰竭及死亡风险相关的证据,评估证据对临床实践和患者风险感知的影响,并综合PPI减处方文献,提出关于如何使用和减处方的建议。
要点
- PPI使用与低镁血症、急性肾损伤、急性间质性肾炎、慢性肾脏病及肾病进展等肾脏不良结局相关。
- PPI常无医学指征使用,有指征时也常超所需时长使用,且很少减处方。
- 临床应评估PPI使用指征和疗程,并参考本文建议进行减处方。
核心结论
- PPI使用与多种肾脏不良结局及全因死亡和慢性肾脏病死亡风险增加相关。
- 临床需重新评估PPI使用指征与疗程,并实施减处方策略。
研究设计与样本
- 本文为In Practice综述,总结PPI使用与不良事件尤其肾脏不良结局的文献证据。
主要发现
- PPI使用与低镁血症、急性肾损伤、急性间质性肾炎、新发慢性肾脏病、肾病进展、肾衰竭、全因死亡及慢性肾脏病死亡风险增加相关。
- PPI处方量大、极少减处方,且常可非处方购买,常无医学指征使用或超所需时长使用。
临床怎么用
- 临床应评估PPI使用指征,避免无指征使用,并在有指征时控制疗程。
- 应参考本文减处方文献和推荐,对患者实施PPI减处方。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Proton pump inhibitors (PPIs), long thought to be safe, are associated with a number of nonkidney adverse health outcomes and several untoward kidney outcomes, including hypomagnesemia, acute kidney injury, acute interstitial nephritis, incident chronic kidney disease, kidney disease progression, kidney failure, and increased risk for all-cause mortality and mortality due to chronic kidney disease. PPIs are abundantly prescribed, rarely deprescribed, and frequently purchased over the counter. They are frequently used without medical indication, and when medically indicated, they are often used for much longer than needed. In this In Practice review, we summarize evidence linking PPI use with adverse events in general and adverse kidney outcomes in particular. We review the literature on the association of PPI use and risk for hypomagnesemia, acute kidney injury, acute interstitial nephritis, incident chronic kidney disease, kidney disease progression, end-stage kidney disease, and death. We provide an assessment of how this evidence should inform clinical practice. We review the impact of this evidence on patients' perception of risk, synthesize PPI deprescription literature, and provide our recommendations on how to approach PPI use and deprescription.
引用
- Al-Aly Z, Maddukuri G, Xie Y, et al. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe. Am J Kidney Dis. 2019. PMID: 31606235. doi:10.1053/j.ajkd.2019.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。